SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-04-001287
Filing Date
2004-04-02
Accepted
2004-04-02 16:41:17
Documents
3
Period of Report
2004-05-05
Effectiveness Date
2004-04-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT w95135dfdef14a.htm DEF 14A 255447
3 GRAPHIC w95135dfw9513501.gif GRAPHIC 5714
4 GRAPHIC w95135dfvotebar.gif GRAPHIC 10165
  Complete submission text file 0000950133-04-001287.txt   273140
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 04714518
SIC: 2836 Biological Products, (No Diagnostic Substances)